PFS-1144

N/A

Report date: 2022/02/17 13:32:28
NME

Base Information

Drug NamePFS-1144
Drug Alias NameEO-122PFS-1144
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel alpha subunit blockersVoltage-gated calcium channel blockers
TargetsSodium channel alpha subunitVoltage-gated calcium channel
Therapy Area/IndicationsArrhythmias, Cardiac
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEisai Co LtdPurdue Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPurdue PharmaEisai Co Ltd
Active IndicationsN/A
Inactive IndicationsArrhythmias, Cardiac

Other Information

ATC CodeN/A
Related LinksN/A